Rankings
▼
Calendar
BOLD Q1 2017 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-0.83
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$122M
Total Liabilities
$19M
Stockholders' Equity
$103M
Cash & Equivalents
$19M
← FY 2017
All Quarters
Q2 2017 →